These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 12777580)

  • 21. Impact of recommendations to suspend the birth dose of hepatitis B virus vaccine.
    Oram RJ; Daum RS; Seal JB; Lauderdale DS
    JAMA; 2001 Apr; 285(14):1874-9. PubMed ID: 11308401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening of pregnant women for hepatitis B virus surface antigen (HBsAg) and subsequent management, Qiandongnan prefecture, Guizhou, China, 2010.
    Huang Y; Li L; Sun X; Lu M; Liu H; Tang G; Wang D; Hutin YJ
    Vaccine; 2013 Dec; 31 Suppl 9():J62-5. PubMed ID: 24331022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Applicability and efficacy of a model for prevention of perinatal transmission of hepatitis B virus infection: single center study in Egypt.
    El-Karaksy HM; Mohsen LM; Saleh DA; Hamdy MS; Yassin NA; Farouk M; Salit ME; El-Shabrawi MH
    World J Gastroenterol; 2014 Dec; 20(45):17075-83. PubMed ID: 25493019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Predictive study of HBsAg in different stages of neonatal venous blood on failure of blocking HBV mother to infant transmission].
    Yi W; Li MH; Hu YH; Liu F; Zhang YL; Liu XJ; Hao HX; Song SJ; Liu Y; Li XH; Sun JY; Liu M; Cheng J; Xie Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):338-41. PubMed ID: 22338218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
    Yin YZ; Zhou J; Zhang PZ; Hou HY
    Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of perinatal transmission of hepatitis B to babies at high risk: an evaluation.
    Sloan D; Ramsay M; Prasad L; Gelb D; Teo CG
    Vaccine; 2005 Dec; 23(48-49):5500-8. PubMed ID: 16112253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An efficacy trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine in infants born to mothers positive for HBsAg, in Shanghai, China.
    Halliday ML; Kang LY; Rankin JG; Coates RA; Corey PN; Hu ZH; Zhou TK; Yuan GJ; Yao FL
    Int J Epidemiol; 1992 Jun; 21(3):564-73. PubMed ID: 1386063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From the Centers for Disease Control and Prevention. Impact of the 1999 AAP/USPHS Joint Statement on Thimerosal in Vaccines on Infant Hepatitis B Vaccination Practices. American Academy of Pediatrics/U.S. Public Health Service.
    JAMA; 2001 Mar; 285(12):1568-70. PubMed ID: 11302135
    [No Abstract]   [Full Text] [Related]  

  • 29. Improved immunization practices reduce childhood hepatitis B infection in Tonga.
    Danielsson N; Fakakovikaetau T; Szegedi E
    Vaccine; 2009 Jul; 27(33):4462-7. PubMed ID: 19508908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B immunisation coverage of infants born to chronic carrier mothers in Victoria.
    Oman KM; Carnie J; Ruff T
    Aust N Z J Public Health; 1997 Dec; 21(7):731-4. PubMed ID: 9489190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A retrospective study of hepatitis B mother-to-child transmission prevention and postvaccination serological test results of infants at risk of perinatal transmission in two counties of middle China.
    Yonghao G; Pumei D; Jianhui Y; Jin X; Yanyang Z; Zhe W
    J Viral Hepat; 2017 Aug; 24(8):687-695. PubMed ID: 28199772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Influencing factors for non/low-response to hepatitis-B vaccine in infants of HBsAg positive mothers].
    Wang B; Xu XX; Wen HX; Hao HY; Yang ZQ; Shi XH; Fu ZD; Wang XF; Zhang F; Wang B; Wang SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):911-915. PubMed ID: 28738465
    [No Abstract]   [Full Text] [Related]  

  • 33. Perinatal hepatitis B prevention program in Shandong Province, China. Evaluation and progress.
    Zhang L; Ko S; Lv J; Ji F; Yan B; Xu F; Xu A
    Hum Vaccin Immunother; 2014; 10(9):2755-60. PubMed ID: 25483482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of a programme for prevention of vertical transmission of hepatitis B in a rural block in southern India.
    Alexander AM; Prasad JH; Abraham P; Fletcher J; Muliyil J; Balraj V
    Indian J Med Res; 2013 Feb; 137(2):356-62. PubMed ID: 23563380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serologic Responses After Hepatitis B Vaccination in Preterm Infants Born to Hepatitis B Surface Antigen-Positive Mothers: Singapore Experience.
    Tan CX; Chan SM; Lee LY; Ong C; Phua KB; Aw MM; Saw S; Lee GH; Wong F; Thoon KC
    Pediatr Infect Dis J; 2017 Aug; 36(8):e208-e210. PubMed ID: 28198787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of screening for hepatitis B surface antigen during pregnancy in a population with a high prevalence of hepatitis B surface antigen-positive/hepatitis B e antigen-negative carriers.
    Zamir C; Dagan R; Zamir D; Rishpon S; Fraser D; Rimon N; Ben Porath E
    Pediatr Infect Dis J; 1999 Mar; 18(3):262-6. PubMed ID: 10093949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody response to postexposure prophylaxis in infants born to hepatitis B surface antigen-positive women.
    Euler GL; Copeland JR; Rangel MC; Williams WW
    Pediatr Infect Dis J; 2003 Feb; 22(2):123-9. PubMed ID: 12586975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization status and factors influencing hepatitis B vaccination of preterm infants in three provinces of China, 2019 to 2021.
    Huang LF; Huang AD; Zhang X; Tang L; An J; Li J; Zheng H; Yin ZD; Wang FZ
    BMC Infect Dis; 2024 Sep; 24(1):951. PubMed ID: 39256653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants.
    Pan CQ; Zou HB; Chen Y; Zhang X; Zhang H; Li J; Duan Z
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1349-55. PubMed ID: 23639606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship between the HBsAg-positive infection status of mothers and the non/low-response to hepatitis B vaccine of their infants].
    Yang ZQ; Hao HY; Shi XH; Fu ZD; Zhang F; Wang XF; Xu XX; Wang B; Wen HX; Feng SY; Wang B; Wang SP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jun; 39(6):805-809. PubMed ID: 29936751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.